Purpose: Although advancement in treatment and diagnostic tools related to hepatocelluar carcinoma has been much improved, long term survival rates of hepatocellular carcinoma are still low because of delayed clinical manifestations and underlying diseases causing the cancer. Various kinds of modalities to treat hepatocellular carcinoma have developed but surgical resection is still recognized as the best method. Therefore, we studied the associated factors of long-term survival after liver resection. Methods: We retrospectively analyzed 184 patients who were pathologically diagnosed with hepatocellular carcinoma from May 1990 to December 2002. Associated factors of long-term survival classified as preoperative, operative, pathological and recurrence factors. Univariate and multivariate analyses were done using cross tabulation analysis and logistic regression analysis. Results: The cumulative 1 , 3 and 5 year survival rates were 66%, 50% and 30%, respectively. Preoperative factors, significantly associated with long-term survival, were age of 60 years and under, tumor size, HBe Ag status and preoperative tumor marker level. As pathological factors, the vascular invasion and lymphatic invasion status were significantly associated. But cirrhosis of the liver was not associated with long-term survival. And in cases of recurrence, patients who had undergone repeat resection survived significantly longer. Conclusion: The most significant factors of multivariate analyses were lymphatic invasion status. Tumor size, ICG˗R15 and HBe Ag status followed second. We should correct the preoperative factors through screening and early diagnosis. And when recurrence occurs, if the recurring cancer has resectability, repeat hepatectomy will increase the patient's lifespan. (J Korean Surg Soc 2009;76:225˗230) 서 론 간세포암은 임상증상이 늦게 나타나 조기 진단이 어렵고, 다발성 발생의 경향을 띄고 있다. 또한, 간세포암은 간염 및 간경변 등의 간세포암의 원인이 되는 동반질환이 흔하고, 빈 번한 간 내 전이 및 재발로 인해 타 암종과 비교해 장기생존 율이 좋지 못하다.(1,2) 간세포암은 남성암의 16.1%로 국내 남성 암 발생률의 3위를 차지하고 있으며, 여성 암의 6.7%를 차지하고 있다.(3) 우리나라는 B형 간염의 유병률이 5∼8% 로 보고되고 있어 외국의 5%보다 그 빈도가 높으며 따라서 간염에 의한 간세포암의 발병률도 높은 수준이다. 최근 간동맥색전술(TAE), 경피적에탄올주입법(PIET) 등 의 다양한 방법으로 간세포암의 치료가 시도되고 있으며,
Male Female Age ＜60 (years) ≥60 (years) Tumor size ＜5 cm ≥5 cm ICG ＜10 (%) ≥10 (%) Child-Pugh A Classification B, C Solitary Multiple HBe Ag (−) (＋) AFP* ＜20 (ng/dl) ≥20 (ng/dl) Cirrhosis (−) (＋) Vascular invasion (−) (＋) Portal vein thrombosis (−) (＋) Capsule formation (−) (＋) Lymphatic invasion (−) (＋) Repeat resection (−)(＋)
